CD8A and neoplasm: Combined, these findings suggest that MIF promotes tumor-associated immune evasion by inhibiting DC infiltration, maturation, and antigen presentation; all of which are inherently required for the development of anti-tumor CD4+ and CD8+ T cell effector functions.